Prior to initiating acute mechanical circulatory support (AMCS) for cardiogenic shock (CS), vasoactive agents are used for hemodynamic support to avert multi-system dysfunction or hemo-metabolic shock. We explored the relationship… Click to show full abstract
Prior to initiating acute mechanical circulatory support (AMCS) for cardiogenic shock (CS), vasoactive agents are used for hemodynamic support to avert multi-system dysfunction or hemo-metabolic shock. We explored the relationship between vasoactive agents and clinical outcomes in CS. We
               
Click one of the above tabs to view related content.